COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,609 Articles (22,913 medRxiv, 8,696 bioRxiv)

Most recent first Previous |  Page 607: Articles 6061-6070  | Next

The CANDID Study: impact of COVID-19 on critical care nurses and organisational outcomes: implications for the delivery of critical care services. A questionnaire study before and during the pandemic.
McCallum, L., Rattray, J., Pollard, B., Millar, J., Hull, A., Ramsay, P., Salisbury, L., Scott, T., Cole, S., Dixon, D.
10.1101/2022.11.16.22282346 — Posted: 2022-11-18
Efficacy of the wild-type/Omicron BA.1 bivalent vaccine as the second booster dose against Omicron BA.2 and BA.5
Kawasuji, H., Morinaga, Y., Tani, H., Saga, Y., Yamada, H., Yoshida, Y., Takegoshi, Y., Kaneda, M., Murai, Y., Kimoto, K., Ueno, A., Miyajima, Y., Nagaoka, K., Ono, C., Matsuura, Y., Niimi, H., Yamamoto, Y.
10.1101/2022.11.15.22282328 — Posted: 2022-11-18
Improved Neutralization of Omicron BA.4/5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent BA.4/5 Vaccine
Zou, J., Kurhade, C., Patel, S., Kitchin, N., Tompkins, K., Cutler, M., Cooper, D., Yang, Q., Cai, H., Muik, A., Zhang, Y., Lee, D.-Y., Sahin, U., Anderson, A. S., Gruber, W. C., Xie, X., Swanson, K. A., Shi, P.-Y.
10.1101/2022.11.17.516898 — Posted: 2022-11-17
Effect of surfactants on SARS-CoV-2: Molecular Dynamics Simulations
Domingo, M., Faraudo, J.
10.1101/2022.11.17.516905 — Posted: 2022-11-17
Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies
Planas, D., Bruel, T., Staropoli, I., Guivel-Benhassine, F., Porrot, F., Maes, P., Grzelak, L., Prot, M., Mougari, S., Planchais, C., Puech, J., Saliba, M., Sahraoui, R., Femy, F., Morel, N., Dufloo, J., Sanjuan, R., Mouquet, H., Andre, E., Hocqueloux, L., Simon-Loriere, E., Veyer, D., Prazuck, T., Pere, H., Schwartz, O.
10.1101/2022.11.17.516888 — Posted: 2022-11-17
Global spatiotemporal trends and determinants of COVID-19 vaccine acceptance on Twitter: a multilingual deep learning study in 135 countries and territories
Zhou, X., Zhang, X., Larson, H. J., de Figueiredo, A., Jit, M., Fodeh, S., Vermund, S. H., Zang, S., Lin, L., Hou, Z.
10.1101/2022.11.14.22282300 — Posted: 2022-11-17
The prevalence of probable mental health disorders among hospital healthcare workers during COVID-19: A systematic review and meta-analysis
Lee, B. E. C., Ling, M., Boyd, L., Sheen, J.
10.1101/2022.11.16.22282426 — Posted: 2022-11-17
Particulate matter air pollution and COVID-19 infection, severity, and mortality: A systematic review
Sheppard, N., Carroll, M., Gao, C. X., Lane, T. J.
10.1101/2022.11.16.22282100 — Posted: 2022-11-17
A single-centre, observational study to evaluate immune response to Covid-19 vaccines in immunocompromised patients with haematological disorders (COVAC-IC)
CHANDRA, D., COAVC-IC INVESTIGATORS, , O'Mara, L., Bailey, L., Aspey, M., Asaduzzaman, M., Banavathi, K., Lea, S., Bowler, R., Prasangika, J., Phillips, N., Wasim, F., Badugama, B., Kamran, N., Perera, K., Bano, F., Pillai, S., Dyer, P., Aquil, M., Goddard, S., Ogbolosingha, A., Remegoso, A., Lee, J., Watts, K., Karunanithi, K.
10.1101/2022.11.16.22282121 — Posted: 2022-11-17
Observational methods for COVID-19 vaccine effectiveness research: a trial emulation and empirical evaluation
Catala, M., Burn, E., Rathod-Mistry, T., Xie, J., Delmestri, A., Prieto-Alhambra, D., Jodicke, A. M.
10.1101/2022.11.09.22282065 — Posted: 2022-11-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).